FDA Adverse Event Malfunction Summary report: N

INFUSOR

MDR report key: 10353456 · Received July 31, 2020

Report

Report Number
1416980-2020-04605
Event Type
Malfunction
Date Received
July 31, 2020
Date of Event
July 5, 2020
Report Date
September 4, 2020
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
MEB
UDI-DI
00085412081366
PMA / PMN Number
K071222
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION WAS ADDED TO H4 AND H6: H4: THE DEVICE WAS MANUFACTURED FROM DECEMBER 3, 2019 - DECEMBER 4, 2019. H10: A BATCH REVIEW WAS CONDUCTED AND THERE WERE NO DEVIATIONS FOUND RELATED TO THIS REPORTED CONDITION DURING THE MANUFACTURE OF THIS LOT. THE DEVICE WAS NOT RECEIVED FOR EVALUATION; THEREFORE, A DEVICE ANALYSIS COULD NOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(6). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A LARGE VOLUME INFUSOR UNDERINFUSED DURING PATIENT INFUSION; 65ML OF SOLUTION REMAINED IN THE DEVICE. THE DEVICE HAD BEEN FILLED WITH 13500MG PIPERACILLIN/TAZOBACTAM IN 0.9% SODIUM CHLORIDE. THERE WAS NO REPORT OF PATIENT INJURY OR MEDICAL INTERVENTION ASSOCIATED WITH THIS EVENT. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
817728 INFUSOR PUMP, INFUSION, ELASTOMERIC MEB BAXTER HEALTHCARE CORPORATION NA 19N019 00085412081366

Patients

Seq Age Sex Outcome Treatment
1 PIPERACILLIN/TAZOBACTAM 13500MG| SODIUM CHLORIDE 0.9%